[ad_1]

Five Chinese-linked biotechnology firms won a reprieve Saturday when negotiators on a key defense bill decided not to include legislation blacklisting the companies from new federally funded research and contracts.
[ad_2]
Source link
[ad_1]
[ad_2]
Source link
Sign in to your account